News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
141 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32753)
Month
January (2936)
February (2969)
March (2710)
April (2907)
May (3626)
June (2409)
July (2088)
August (2589)
September (2381)
October (3064)
November (3190)
December (1884)
Day
2 (21)
3 (149)
4 (290)
5 (296)
6 (241)
7 (145)
10 (297)
11 (166)
12 (61)
13 (229)
14 (184)
17 (126)
18 (144)
19 (137)
20 (141)
21 (143)
24 (150)
25 (65)
26 (125)
27 (69)
28 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Job Trends
Hiring Outlook: Job Openings Will Likely Drop as 2025 Winds Down But Could Rise in 2026
Biopharma professionals will probably find decreasing employment opportunities this month and next even as layoffs continue, based on
BioSpace
data. However, hundreds of open roles are expected this year in Massachusetts, and a job market turnaround could start late next year.
November 20, 2025
·
4 min read
·
Angela Gabriel
Approvals
FDA Hands Regeneron Two Eylea HD Nods in One Day
The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns.
November 20, 2025
·
2 min read
·
Tristan Manalac
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
C-suite
Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T
The drugmaker’s dominance of the obesity market is fueling predictions that years of growth lie ahead.
November 20, 2025
·
5 min read
·
Nick Paul Taylor
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Regulatory
FDA Breakthrough Designations Lead to Priority Reviews, Report Finds
A new analysis from Jefferies shows that drugs receiving breakthrough designations sail through the regulatory process more quickly, on top of frequently winning approval.
November 20, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
November 20, 2025
·
4 min read
Press Releases
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
November 20, 2025
·
3 min read
Press Releases
EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
November 20, 2025
·
11 min read
Press Releases
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
November 20, 2025
·
2 min read
1 of 15
Next